WUWilly Urassa

Willy Urassa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Willy Urassa has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparing Attained Weight and Weight Velocity during the First 6 Months in Predicting Child Undernutrition and Mortality

    by Dongqing Wang, Catherine Schwinger, Willy Urassa, Yemane Berhane, Tor A Strand, Wafaie W Fawzi

    The first 6 mo of life are critical for subsequent risk of undernutrition and mortality. The predictive abilities of attained weight at the end of each month and monthly weight velocity for undernutrition and mortality need to be compared. This study aimed to examine the predictive abilities of different weight metrics during the first 6 mo of life in predicting undernutrition and mortality. This study used a cohort of infants in Tanzania. Weight and length were measured monthly from birth to 18 mo of age. Three weight metrics during the first 6 mo of life were considered as predictors, including attained weight-for-age z score (WAZ) at the end of each month, monthly change in WAZ, and monthly weight velocity z score (WVZ). Logistic models were used with undernutrition (at 6 or 12 mo) and mortality (over the first 18 mo) as outcomes. AUC values were compared across metrics. For predicting wasting at 6 mo, WVZ (AUC: 0.80) had a greater predictive ability than attained WAZ (AUC: 0.76) and change in WAZ (AUC: 0.71) during the second month of life. After 2 mo, attained WAZ (AUC: 0.81–0.89) had greater predictive abilities than WVZ (AUC: 0.71–0.77) and change in WAZ (AUC: 0.65–0.67). For predicting stunting at 6 mo, attained WAZ (AUC: 0.75–0.79) had consistently greater predictive abilities than WVZ (AUC: 0.56–0.66) and change in WAZ (AUC: 0.50–0.57). The weight metrics had similar abilities in predicting mortality, with the AUC rarely reaching >0.65. Attained weight at the end of each month had greater abilities than monthly weight velocity in the same month in predicting undernutrition. Attained weight remains a useful indicator for identifying infants at greater risk of undernutrition.


  • ReEBOV Antigen Rapid Test kit for Ebola

    by Willy Urassa, Robyn Meurant, David Wood


  • Open Access

    Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania

    by K. Kawai, E. Villamor, F.M. Mugusi, E. Saathoff, W. Urassa, R.J. Bosch, D. Spiegelman, W.W. Fawzi

    BACKGROUND: Patients with tuberculosis (TB) often suffer from profound malnutrition. OBJECTIVE: To examine the patterns and predictors of change in nutritional and hemoglobin status during and after TB treatment. METHODS: A total of 471 human immunode ciency virus (HIV) positive and 416 HIV-negative adults with pulmonary TB were prospectively followed in Dar es Salaam, Tanzania. All patients received 8 months' TB treatment following enrollment. RESULTS: About 40% of HIV-positive and 47% of HIVnegative TB patients had body mass index (BMI) < 18.5 kg/m 2 at baseline, while about 94% of HIV-positive and 84% of HIV-negative participants were anemic at baseline. Both HIV-positive and HIV-negative patients experienced increases in BMI and hemoglobin concen- trations over the course of TB treatment. Among HIV- positive patients, older age, low CD4 cell counts, and high viral load were independently associated with a smaller increase in BMI from baseline to 8 months. Fe- male sex, older age, low CD4 cell counts, previous TB in- fection and less money spent on food were independently associated with a smaller improvement in hemoglobin levels among HIV-positive patients during treatment. CONCLUSION: HIV-positive TB patients, especially those with low CD4 cell counts, showed poor nutritional re- covery during TB treatment. Adequate nutritional sup- port should be considered during TB treatment. Spanish MARCO DE REFERENCIA: Los pacientes con tuberculosis (TB) suelen sufrir de desnutrición grave. OBJETIVO: Examinar los factores pronósticos y las modalidades de la evolución del estado nutricional antes del tratamiento antituberculoso y después del mismo. M É T O D O S : Se practicó el seguimiento de 471 pacientes con infección por el virus de la inmunode ciencia humana (VIH) y 416 pacientes libres de esta infección, todos con TB pulmonar en Dar es Salaam, Tanzanía. Todos los pacientes recibieron 8 meses de tratamiento antituberculoso a partir de su registro. RESULTADOS : Cerca de 40% de los pacientes seropositivos al VIH y 47% de los pacientes seronegativos presentaron un índice de masa corporal (BMI) < 18,5 kg/m 2 al comienzo del estudio. Cerca de 94% de pacientes seropositivos y 84% de pacientes seronegativos sufrían de anemia al comienzo del tratamiento. Ambos grupos de pacientes mejoraron el BMI y la concentración de hemo- globina durante el tratamiento antituberculoso. En los pacientes con infección por el VIH, la edad avanzada, el bajo recuento de células CD4+ y una alta viremia se asociaron en forma independiente con un menor aumento del BMI entre el inicio y el nal de los 8 meses de tratamiento. Los factores que se asociaron con una menor recuperación de la concentración de hemoglobina durante el tratamiento en los pacientes seropositivos fueron el sexo femenino, la edad avanzada, el bajo recuento de células CD4+, el antecedente de infección tuberculosa y el dedicar menos dinero a la compra de alimentos. CONCLUSIÓN: Se observó una escasa recuperación nutricional en los pacientes con serología positiva al VIH durante el tratamiento de la TB, sobre todo cuando presentaban un bajo recuento de células CD4+. Es preciso considerar la administración de un suplemento nutricional adecuado al lado del tratamiento antituberculoso. French CONTEXTE: Les patients atteints de tuberculose (TB) souffrent souvent d'une malnutrition profonde. OBJECTIF: Examiner les types de statut nutritionnel et les facteurs prédictifs de ses modi cations ainsi que du taux d'hémoglobine au cours de et après le traitement TB. MÉTHODES: On a suivi de manière prospective à Dar es Salam, Tanzanie, au total 471 adultes séropositifs pour le virus de l'immunodé cience humaine (VIH) et 416 adultes séronégatifs, atteints de TB pulmonaire. Tous les patients ont reçu un traitement TB de 8 mois après le recrutement. RÉSULTATS: Au départ, l'index de masse corporelle (BMI) est < 18,5 kg/m 2 chez environ 40% des patients TB séropositifs pour le VIH et chez 47% des patients TB séronégatifs. Au départ, l'anémie existe chez environ 94% des séropositifs et 84% des séronégatifs participant à l'étude. Au cours du traitement de la TB, on note, tant chez les patients séropositifs que chez les séronégatifs, une augmentation du BMI et des concentrations d'hémoglobine. Parmi les patients séropositifs, les facteurs en association avec une augmentation plus faible au 8ème mois du BMI du départ sont l'âge plus avancé, des décomptes plus bas de cellules CD4 et les charges virales élevées. Le sexe féminin, l'âge plus avancé, des décomptes faibles de CD4, une infection antérieure par la TB et des dépenses moindres pour l'alimentation sont des facteurs en association indépendante avec une amélioration moins marquée de l'hémoglobine chez les patients séropositifs au cours du traitement. CONCLUSION: La récupération nutritionnelle est médiocre au cours du traitement TB chez les patients TB séropositifs pour le VIH, particulièrement ceux dont le décompte de cellules CD4 est bas. Un complément alimentaire adéquat pourrait être envisagé au cours du traitement TB.


  • Slow progression of HIV-1 infection in a cohort of antiretroviral naïve hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes

    by Muhammad Bakari, Willy Urassa, Fred Mhalu, Gunnel Biberfeld, Kisali Pallangyo, Eric Sandström

    Data on slow progression following HIV-1 infection in Africa are sparse. From a study on the natural history of HIV-1 infection in Dar es Salaam, Tanzania, an analysis of immunological and clinical data from 237 HIV-1 seropositive individuals was performed. Annual CD4 cell determinations were carried out by flow cytometry. None was on antiretroviral treatment. CD4+ cell slopes were obtained by fitting a linear regression model. A study population of 50 individuals with >3 CD4 cell determinations and followed for >5 y had a mean follow-up of 72.7 months, and mean 5.7 CD4+ cell determinations. With a criterion of maintaining a CD4 cell count >or=500 cells/ml, 8 of the 50 (16.0%) were long-term non-progressors (LTNP). With a definition of maintaining a CD4+ cell slope <or=-10 (a loss of 10 or less cells per y), 13 (26.0%) were long-term slow progressors (LTSP). 11 of them (84.6%) had a baseline CD4 cell count <500 cells/microl and 5(38.5%) had a baseline CD4 cell count less than 350 cells/microl. An analysis of the selection bias introduced during slope determination is presented. With no selection, 24 (23.3%) would have documented slow CD4 progression among those enrolled for 5 or more y regardless of CD4 determinations.


  • Immunological profile of endemic and epidemic Kaposi's sarcoma patients in Dar-es-Salaam, Tanzania.

    by W K Urassa, E E Kaaya, J N Kitinya, L L Lema, H Amir, J Luande, G Biberfeld, F S Mhalu, P Biberfeld

    Kaposi's sarcoma (KS) presents in four clinicopathological types namely classical/sporadic (CKS), endemic African (EKS), iatrogenic (IKS) and that associated with AIDS (AKS). Recently a putative herpes virus (HHV-8) was described and shown to be present in all four types of KS. The immunological status of patients with EKS has been conflicting. In this study total leucocyte counts, total lymphocyte counts and lymphocyte subsets of patients with EKS and AKS were determined by flow cytometry and compared to those of healthy HIV-1 seronegative controls. Results show that 50% of EKS lesions were of nodular type. Patients with EKS had significantly lower levels of CD4+ T- lymphocytes and CD4:CD8 ratio but significantly higher CD8+ T-lymphocytes compared to controls. Patients with AKS had significantly lower levels of CD4+ T-lymphocytes and also CD4:CD8 ratios but significantly higher percentage of CD8+ T-lymphocytes when compared with EKS patients. These findings indicate that in both forms of KS there is a certain degree of immunological disturbance which is more conspicuous in AKS because of HIV infection and suggests that HIV-1 acts synergistically with the aetiological agent (HHV-8) to cause a more aggressive type of KS.